IHC
Immunohistochemical analysis of paraffin-embedded Human stomach cancer tissues using PI3K p85 beta antibody with DAB staining. Pre-treat the sections with heat-mediated antigen retrieval using sodium citrate buffer (pH 6. 0) for 2 minutes. Wash the sections with ddH₂O and PBS. Block the tissue with 10% non-immune goat serum at room temperature for 30 minutes. Incubate the tissue with the primary antibody diluted at a ratio of 1:1500 at 4°C overnight. At room temperature, dilute the secondary antibody, Goat Anti-Rabbit IgG(H&L)-HRP, at a ratio of 1:200 and incubate for one hour. Use DAB as the chromogenic agent. Counterstain the tissue with hematoxylin, and mount the tissue sections with neutral gum.ICC/IF
Immunofluorescence analysis of A549 cells using PI3K p85 beta (green). Blue: DAPI fluorescent DNA dye. Red: Actin filaments have been labeled with TSZ® 594-Phalloidin. Cells are fixed in 4% paraformaldehyde at room temperature for 20 minutes. Then, they are permeabilized with a PBS solution containing 0. 1% Triton X-100 at room temperature for 15 minutes. Subsequently, the cells are blocked with 10% non - immune goat serum at room temperature for 1 hour. The cells are incubated overnight at 4°C with the primary antibody diluted 1:100 in PBS. The secondary antibody, TSZ® 488 Goat Ant-Rabbit IgG(H&L) (Green) is diluted at a ratio of 1:400 and incubated with the cells for 1 hour. Nuclear DNA is labeled with DAPI (Blue). F-actin is stained with TSZ® 594-Phalloidin (Red), diluted 1:100 for 30 minutes.IHC
Immunohistochemical analysis of paraffin-embedded Human colon cancer tissues using PI3K p85 beta antibody with DAB staining. Pre-treat the sections with heat-mediated antigen retrieval using sodium citrate buffer (pH 6. 0) for 2 minutes. Wash the sections with ddH₂O and PBS. Block the tissue with 10% non-immune goat serum at room temperature for 30 minutes. Incubate the tissue with the primary antibody diluted at a ratio of 1:1500 at 4°C overnight. At room temperature, dilute the secondary antibody, Goat Anti-Rabbit IgG(H&L)-HRP, at a ratio of 1:200 and incubate for one hour. Use DAB as the chromogenic agent. Counterstain the tissue with hematoxylin, and mount the tissue sections with neutral gum.IHC
Immunohistochemical analysis of paraffin-embedded Human lung cancer tissues using PI3K p85 beta antibody with DAB staining. Pre-treat the sections with heat-mediated antigen retrieval using sodium citrate buffer (pH 6. 0) for 2 minutes. Wash the sections with ddH₂O and PBS. Block the tissue with 10% non-immune goat serum at room temperature for 30 minutes. Incubate the tissue with the primary antibody diluted at a ratio of 1:1500 at 4°C overnight. At room temperature, dilute the secondary antibody, Goat Anti-Rabbit IgG(H&L)-HRP, at a ratio of 1:200 and incubate for one hour. Use DAB as the chromogenic agent. Counterstain the tissue with hematoxylin, and mount the tissue sections with neutral gum.IHC
Immunohistochemical analysis of paraffin-embedded Human rectal cancer tissues using PI3K p85 beta antibody with DAB staining. Pre-treat the sections with heat-mediated antigen retrieval using sodium citrate buffer (pH 6. 0) for 2 minutes. Wash the sections with ddH₂O and PBS. Block the tissue with 10% non-immune goat serum at room temperature for 30 minutes. Incubate the tissue with the primary antibody diluted at a ratio of 1:1500 at 4°C overnight. At room temperature, dilute the secondary antibody, Goat Anti-Rabbit IgG(H&L)-HRP, at a ratio of 1:200 and incubate for one hour. Use DAB as the chromogenic agent. Counterstain the tissue with hematoxylin, and mount the tissue sections with neutral gum.ELISA
Coat the plate with immunizing antigen. Blue line：Immune serum; Orange line: Pre-immune serum.| 抗体类型 | Primary Antibodies |
|---|---|
| 免疫原 | Polypeptide |
| 克隆性 | Polyclonal |
| 同种型 | IgG |
| 宿主 | Rabbit |
| 已测试的应用 | ELISAICC/IFIHC |
| 物种反应性 | HumanMouseRat |
| 浓度 | 1mg/ml |
| 纯化 | Protein A |
| 基因名称 | PIK3R2 |
| 基因别名 | AGM7; GRB1; IMD36; MPPH; MPPH1; p50alpha; p55alpha; p85; p85-ALPHA; p85-BETA; p85alpha; P85B; p85beta; PI3K; PI3KA |
| 基因全称 | phosphoinositide-3-kinase regulatory subunit 2 |
| 基因简介 | Phosphatidylinositol 3-kinase (PI3K) is a lipid kinase that phosphorylates phosphatidylinositol and similar compounds, creating second messengers important in growth signaling pathways. PI3K functions as a heterodimer of a regulatory and a catalytic subunit. The protein encoded by this gene is a regulatory component of PI3K. Three transcript variants, one protein coding and the other two non-protein coding, have been found for this gene. [provided by RefSeq, Apr 2019] |
| 蛋白别名 | growth factor receptor bound 1; p85-alpha; GRB1; phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha; phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta; phosphatidylinositol 3-kinase p85 alpha; phosphatidylinositol 3-kinase, regulartory subunit, polypeptide 2; phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha); phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta); phosphatidylinositol 3-kinase-associated p-85 alpha; Phosphoinositide 3-kinase p85 (other splicing variants: p55 and p50); Phosphoinositide 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha); phosphoinositide-3-kinase regulatory subunit alpha; phosphoinositide-3-kinase regulatory subunit beta; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); phosphoinositide-3-kinase, regulatory subunit 2 (beta); PI3 kinase-associated p85; PI3-kinase p85 subunit alpha; PI3-kinase p85 subunit beta; PI3-kinase regulatory subunit alpha; PI3-kinase regulatory subunit beta; PI3-kinase subunit p85-alpha; PI3-kinase subunit p85-beta; PI3K regulatory subunit alpha; PI3K regulatory subunit beta; PI3K-p46; ptdIns-3-kinase p85-alpha; ptdIns-3-kinase p85-beta; ptdIns-3-kinase regulatory subunit alpha; ptdIns-3-kinase regulatory subunit beta; ptdIns-3-kinase regulatory subunit p85-alpha; ptdIns-3-kinase regulatory subunit p85-beta |
| 分子量 | 81 kDa |
| Uniprot ID | O00459 |
| 应用稀释比 |
IHC:1:200-1:2000 ICC/IF:1:100-1:500 ELISA:1:1000-1:10000 |
| 修饰 | Unmodification |
| 标记 | Unconjugated |
| 亚细胞定位 | Cytoplasmic;nucleus |
| 产品形态 | Liquid |
| 缓冲液 | Purified antibody in PBS with 0.05% sodium azide,40% Glycerol. |
| 保存条件 | Shipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C long term. Avoid freeze / thaw cycle. |
请在以下方框中输入您的动物实验信息后点击计算，可以得到母液配置方法和体内配方的制备方法：
比如您的给药剂量是10 mg/kg，每只动物体重20 g，给药体积100 μL， 一共给药动物10只，您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O， 那么您的工作液浓度为2 mg/mL。
母液配置方法：2 mg 药物溶于 100 μL DMSO （ 母液浓度为 20 mg/mL ）, 如您需要配置的浓度超过该产品的溶解度，请先与我们联系。
体内配方的制备方法： 取 100 μL DMSO 母液， 添加 400 μL PEG300 混匀澄清， 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清
以上为“体内实验配液计算器”的使用方法举例，并不是具体某个化合物的推荐配制方式，请根据您的实验动物和给药方式选择适当的溶解方案。
方案所需的各类助溶剂如： DMSO， PEG300， PEG400， Tween 80， SBE-β-CD， 玉米油等， 均可在诺渊网站点击购买。
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL Saline/PBS/ddH2O，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
